Novartis AG

NVS | NYSE

Price Alert Chart Builder DCF Calculator

$141.04

+$0.06 (+0.04%)

Sep 22, 2026, 1:36 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 28, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	14.42B	13.52B	13.33B	14.36B	14.84B	13.62B	13.56B	13.17B	12.87B	12.12B	11.78B	12.09B	11.75B	11.05B	13.09B	10.78B	13.09B	12.81B	13.52B	13.37B	13.29B	12.69B
Cost of Revenue	3.68B	3.46B	3.54B	3.54B	3.32B	3.23B	3.32B	3.23B	3.17B	3.1B	3.02B	3.12B	3.34B	2.99B	4.07B	2.87B	3.75B	3.86B	3.98B	3.94B	3.91B	4.04B
Gross Profit	10.74B	10.07B	9.79B	10.82B	11.51B	10.39B	10.23B	9.94B	9.7B	9.02B	8.75B	8.98B	8.4B	8.06B	9.01B	7.91B	9.33B	8.96B	9.55B	9.43B	9.38B	8.66B
Operating Income	4.74B	4.24B	3.52B	4.5B	4.86B	4.66B	3.53B	3.63B	4.01B	3.37B	2.58B	1.76B	2.81B	2.62B	1.95B	1.83B	2.23B	2.85B	2.56B	3.23B	3.48B	2.42B
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	4.27B	3.84B	3.22B	4.2B	4.53B	4.41B	3.29B	3.39B	3.84B	3.13B	2.38B	1.55B	2.67B	2.52B	1.74B	1.59B	2.04B	2.67B	16.95B	3.23B	3.51B	2.45B
Net Income	3.27B	3.16B	2.41B	3.93B	4.04B	3.61B	2.82B	3.19B	3.25B	2.69B	8.48B	1.76B	2.32B	2.29B	1.47B	1.57B	1.69B	2.22B	16.31B	2.76B	2.9B	2.06B
Selling & General & Admin	3.24B	3.14B	3.44B	3.31B	3.44B	3.06B	3.5B	3.13B	3.09B	2.84B	3.44B	3.09B	3.09B	2.89B	3.75B	2.94B	3.58B	3.51B	3.99B	3.62B	3.75B	3.53B
Research & Development	2.76B	2.74B	2.84B	2.94B	2.73B	2.37B	2.84B	2.39B	2.37B	2.42B	2.57B	3.93B	2.3B	2.58B	2.44B	2.54B	2.5B	2.32B	2.41B	2.38B	2.4B	2.35B
Other Expenses	n/a	-50M	n/a	66M	481M	306M	361M	785M	227M	390M	161M	197M	201M	-28M	876M	605M	1.03B	274M	590M	198M	-253M	360M
Operating Expenses	6B	5.83B	6.27B	6.32B	6.65B	5.73B	6.7B	6.31B	5.69B	5.65B	6.17B	7.21B	5.6B	5.44B	7.07B	6.08B	7.11B	6.11B	6.98B	6.2B	5.9B	6.24B
Interest Expense	462.32M	343M	303.98M	281M	293.64M	270.22M	273.05M	266.88M	245.62M	219.74M	238.87M	222M	215.85M	200.47M	241.37M	206M	202M	201M	206M	202M	201M	202M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	9.68B	9.29B	9.81B	9.86B	9.97B	8.96B	10.03B	9.55B	8.86B	8.75B	9.19B	10.33B	8.94B	8.43B	11.14B	8.96B	10.86B	9.96B	10.96B	10.13B	9.82B	10.28B
Income Tax Expense	1.01B	683M	813.94M	266M	507M	798M	465M	200M	595M	441M	-261M	39M	403M	370M	275M	257M	347M	450M	645M	472M	611M	391M
Shares Outstanding (Basic)	1.91B	1.91B	1.91B	1.93B	1.95B	1.97B	1.99B	2.01B	2.03B	2.04B	2.05B	2.06B	2.08B	2.11B	2.14B	2.17B	2.2B	2.23B	2.24B	2.24B	2.24B	2.25B
Shares Outstanding (Diluted)	1.91B	1.92B	1.93B	1.94B	1.96B	1.98B	2B	2.03B	2.05B	2.06B	2.07B	2.08B	2.1B	2.12B	2.15B	2.18B	2.21B	2.24B	2.25B	2.25B	2.26B	2.27B
EPS (Basic)	1.71	1.65	1.26	2.04	2.07	1.83	1.42	1.58	1.60	1.32	4.14	0.85	1.11	1.09	0.69	0.73	0.77	1	7.29	1.23	1.29	0.91
EPS (Diluted)	1.71	1.65	1.25	2.02	2.06	1.82	1.41	1.57	1.59	1.31	4.11	0.85	1.11	1.08	0.68	0.72	0.77	0.99	7.24	1.22	1.28	0.91
EBITDA	5.94B	5.41B	5.07B	5.84B	6.08B	5.83B	5.19B	5.61B	5.25B	4.66B	4.18B	4.89B	4.6B	4.59B	3.91B	3.71B	4.05B	4.28B	18.68B	4.89B	5.15B	4.35B
EBIT	4.74B	4.18B	3.52B	4.48B	4.82B	4.68B	3.56B	3.65B	4.09B	3.35B	2.59B	1.77B	2.89B	2.72B	1.96B	1.79B	2.24B	2.87B	17.16B	3.43B	3.71B	2.65B
Depreciation & Amortization	1.2B	1.23B	1.55B	1.36B	1.26B	1.15B	1.63B	1.97B	1.16B	1.31B	1.59B	3.11B	1.71B	1.87B	1.95B	1.92B	1.8B	1.41B	1.52B	1.45B	1.44B	1.7B